Perfil farmacoterapêutico de pacientes obesos no pós-operatório de cirurgia bariátrica
Pharmacotherapeutic profile of obese patients during the postoperative period after bariatric surgery
Elenara Simoni Kovaleski, Helena Schroeder, Mauricio Krause, Caroline Dani, PatrÃcia Martins Bock
Resumo
Contexto: A obesidade pode estar relacionada a doenças como diabetes, hipertensão arterial e dislipidemia. A cirurgia bariátrica é um dos tratamentos mais eficazes, levando à diminuição de peso e comorbidades. Objetivo: Avaliar o perfil metabólico e farmacoterapêutico de pacientes obesos após cirurgia bariátrica. Métodos: Trata-se de um estudo observacional transversal retrospectivo, realizado em um hospital localizado na cidade de Porto Alegre, RS, Brasil. Foram avaliados 70 prontuários de pacientes que realizaram cirurgia bariátrica, nos perÃodos de antes de 2 meses e mais de 6 meses após a cirurgia bariátrica. A análise estatÃstica foi realizada no programa SPSS 17.0. Resultados: A pressão arterial inicial foi de 130/85 mmHg, passando para 120/80 mmHg (p < 0,01). Com relação ao perfil metabólico antes de dois meses, o HDL foi de 34 mg/dL, o colesterol total foi de 195,07 ± 40,17 mg/dL, o LDL foi de 118,22 ± 41,28 mg/dL, os triglicerÃdeos foram de 141,09 ± 43,39 mg/dL, e a glicemia de jejum foi de 90 mg/dL. Após 6 meses de cirurgia, os valores passaram para 43 mg/dL, 133,67 ± 28,14 mg/dL, 65,53 ± 24,3 mg/dL, 104,41 ± 29,6 mg/dL, e 77 mg/dL, respectivamente (p < 0,01). Com relação ao uso de medicamentos, 41% utilizaram anti-hipertensivos, 39% utilizaram hipolipemiantes, 10% utilizaram hipoglicemiantes orais e 97% utilizaram suplementos antes dos 2 meses de cirurgia. Após os 6 meses, os percentuais foram alterados para 21%, 19%, 9% e 99%, respectivamente. Conclusões: O estudo mostra o sucesso da cirurgia bariátrica em pacientes obesos com comorbidades, revelando melhora no perfil metabólico e redução na utilização de medicamentos para tratamento de comorbidades.
Palavras-chave
Abstract
Background: Obesity can be associated with diseases such as diabetes, arterial hypertension and dyslipidemia. Bariatric surgery is one of the most effective treatments available, reducing both weight and comorbidities. Objective: To evaluate the metabolic and pharmacotherapeutic profile of obese patients after bariatric surgery. Methods: This is a retrospective, cross-sectional, observational study conducted at a hospital located in the city of Porto Alegre, RS, Brazil, based on analysis of the medical records for 70 patients who underwent bariatric surgery covering periods spanning from 2 months prior to more than 6 months after their bariatric surgery. Statistical analysis was conducted using SPSS 17.0. Results: Initial arterial blood pressure was 130/85 mmHg, 6 months after surgery it was 120/80 mmHg (p < 0.01). The metabolic profile 2 months before surgery was as follows: HDL was 34 mg/dL, total cholesterol was 195.07 ± 40.17 mg/dL, LDL was 118.22 ± 41.28 mg/dL, triglycerides were 141.09 ± 43.39 mg/dL, and fasting glycemia was 90 mg/dL. The same figures 6 months after surgery were 43 mg/dL, 133.67 ± 28.14 mg/dL, 65.53 ± 24.3 mg/dL, 104.41 ± 29.6 mg/dL, and 77 mg/dL, respectively (p < 0.01). Use of medications 2 months before surgery was as follows: 41% were on antihypertensives, 39% on hypolipidemics, 10% on oral hypoglycemics, and 97% were on nutritional supplements. These percentages 6 months after surgery had changed to 21%, 19%, 9% and 99%, respectively. Conclusions: This study illustrates that bariatric surgery for obese patients with comorbidities was successful, demonstrating improvements in their metabolic profile and reductions in use of medications used to treat comorbidities.
Keywords
References
1. Skolnik NS, Ryan DH. Pathophysiology, epidemiology, and assessment of obesity in adults. J Fam Pract. 2014;63(7, Suppl):S3-10. PMid:25198218.
2. World Health Organization. Obesity and overweight. Geneva: WHO; 2015. WHO Fact Sheet, n. 311.
3. Aronson D, Nassar M, Goldberg T, Kapeliovich M, Hammerman H, Azzam ZS. The impact of body mass index on clinical outcomes after acute myocardial infarction. Int J Cardiol. 2010;145(3):476-80. http://dx.doi.org/10.1016/j.ijcard.2009.12.029. PMid:20096942.
4. Artham SM, Lavie CJ, Patel HM, Ventura HO. Impact of obesity on the risk of heart failure and its prognosis. J Cardiometab Syndr. 2008;3(3):155-61. http://dx.doi.org/10.1111/j.1559-4572.2008.00001.x. PMid:18983332.
5. Elrazek AE, Elbanna AE, Bilasy SE. Medical management of patients after bariatric surgery: Principles and guidelines. World J Gastrointest Surg. 2014;6(11):220-8. PMid:25429323.
6. Mathus-Vliegen EM, Basdevant A, Finer N, et al. Prevalence, pathophysiology, health consequences and treatment options of obesity in the elderly: a guideline. Obes Facts. 2012;5(3):460-83. http://dx.doi.org/10.1159/000341193. PMid:22797374.
7. Gerber P, Anderin C, Thorell A. Weight loss prior to bariatric surgery: an updated review of the literature. Scand J Surg. 2015;104(1):33-9. http://dx.doi.org/10.1177/1457496914553149. PMid:25388885.
8. Pories WJ, Mehaffey JH, Staton KM. The surgical treatment of type two diabetes mellitus. Surg Clin North Am. 2011;91(4):821-36, viii. http://dx.doi.org/10.1016/j.suc.2011.04.008. PMid:21787970.
9. Schauer PR, Ikramuddin S, Gourash W, Ramanathan R, Luketich J. Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg. 2000;232(4):515-29. http://dx.doi.org/10.1097/00000658-200010000-00007. PMid:10998650.
10. Valezi AC, Mali J Jr, Menezes MA, Brito EM, Souza SA. Weight loss outcome after silastic ring Roux-en-Y gastric bypass: 8 years of follow-up. Obes Surg. 2010;20(11):1491-5. http://dx.doi.org/10.1007/s11695-010-0264-2. PMid:20811958.
11. Shah M, Simha V, Garg A. Review: long-term impact of bariatric surgery on body weight, comorbidities, and nutritional status. J Clin Endocrinol Metab. 2006;91(11):4223-31. http://dx.doi.org/10.1210/jc.2006-0557. PMid:16954156.
12. Salameh BS, Khoukaz MT, Bell RL et al. Metabolic and nutritional changes after bariatric surgery. Expert Rev Gastroenterol Hepatol. 2010;4(2):217-23. http://dx.doi.org/10.1586/egh.09.67. PMid:20350267.
13. Pech N, Meyer F, Lippert H, et al. Complications, reoperations, and nutrient deficiencies two years after sleeve gastrectomy. J Obes. 2012;2012:828737.
14. Loewen M, Giovanni J, Barba C. Screening endoscopy before bariatric surgery: a series of 448 patients. Surg Obes Relat Dis. 2008;4(6):709-12.
15. Assis P, Silva S, Melo CYSV, Moreira MA. Eating habits, nutritional status and quality of life of patients in late postoperative gastric bypass Roux-Y. Nutr Hosp. 2013;28(3):637-42. PMid:23848082.
16. Hady HR, Dadan J, Gołaszewski P. 100 obese patients after laparoscopic adjustable gastric banding - the influence on BMI, gherlin and insulin concentration, parameters of lipid balance and co-morbidities. Adv Med Sci. 2012;57(1):58-64. http://dx.doi.org/10.2478/v10039-012-0008-8. PMid:22440938.
17. Valezi AC, Mali J Jr, Menezes MA, Brito EM, Souza JC. Weight loss eight years after gastric bypass. Rev Col Bras Cir. 2011;38(4):232-6. http://dx.doi.org/10.1590/S0100-69912011000400006. PMid:21971856.
18. Novais P, Rasera I Jr, Leite C, Oliveira MR. Evolução e classificação do peso corporal em relação aos resultados da cirurgia bariátrica – derivação gástrica em Y de Roux. Arq Bras Endocrinol Metabol. 2010;54(3):303-10. http://dx.doi.org/10.1590/S0004-27302010000300009. PMid:20520961.
19. Hady HR, Golaszewski P, Zbucki RL, Dadan J. The influence of laparoscopic adjustable gastric banding and laparoscopic sleeve gastrectomy on weight loss, plasma ghrelin, insulin, glucose and lipids. Folia Histochem Cytobiol. 2012;50(2):292-303. http://dx.doi.org/10.5603/FHC.2012.0039. PMid:22763970.
20. Heffron SP, Parikh A, Volodarskiy A, et al. Changes in Lipid profile of obese patients following contemporary bariatric surgery: a metaanalysis. Am J Med. 2016;129(9):952-9. http://dx.doi.org/10.1016/j. amjmed.2016.02.004. PMid:26899751.
21. Gulliford MC, Booth HP, Reddy M, et al. Effect of contemporary bariatric surgical procedures on type 2 diabetes remission: a population-based matched cohort study. Obes Surg. 2016 Feb. In press. PMid:26922184.
22. Hady HR, Dadan J, Luba M. The influence of laparoscopic sleeve gastrectomy on metabolic syndrome parameters in obese patients in own material. Obes Surg. 2012;22(1):13-22. http://dx.doi.org/10.1007/s11695-011-0530-y. PMid:21986646.
23. Tritsch AM, Bland CM, Hatzigeorgiou C, Sweeney LB, Phillips M. A retrospective review of the medical management of hypertension and diabetes mellitus following sleeve gastrectomy. Obes Surg. 2015;25(4):642-7. http://dx.doi.org/10.1007/s11695-014-1375-y. PMid:25656260.
24. John S, Hoegerl C. Nutritional deficiencies after gastric bypass surgery. J Am Osteopath Assoc. 2009;109(11):601-4. PMid:19948694.
25. Faria SL, Faria OP, Buffington C, Cardeal MC, Ito MK. Dietary protein intake and bariatric surgery patients: a review. Obes Surg. 2011;21(11):1798-805. http://dx.doi.org/10.1007/s11695-011-0441-y. PMid:21590346.
26. Vargas-Ruiz AG, Hernández-Rivera G, Herrera MF. Prevalence of iron, folate, and vitamin B12 deficiency anemia after laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2008;18(3):288-93. http://dx.doi.org/10.1007/s11695-007-9310-0. PMid:18214631.
27. Katzel EB, Shakir S, Kostereva N, et al. Abnormal vessel archicteture persists in the microvasculature of the massive weight loss patient. Plast Reconstr Surg. 2016;137(1):24e-30e. http://dx.doi.org/10.1097/PRS.0000000000001905. PMid:26710058
28. Domienik-Karłowicz J, Lisik W, Rymarczyk Z, et al. The short-term effect of bariatric surgery on non-invasive markers of artery function in patients with metabolic syndrome. Diabetol Metab Syndr. 2015;7(1):76. http://dx.doi.org/10.1186/s13098-015-0076-6. PMid:26379783.
29. Kral JG, Näslund E. Surgical treatment of obesity. Nat Clin Pract Endocrinol Metab. 2007;3(8):574-83. http://dx.doi.org/10.1038/ncpendmet0563. PMid:17643128.
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email